Dewey Steadman | Head-Investor Relations |
Martine Rothblatt | Chairperson and Chief Executive Officer |
Michael Benkowitz | President and Chief Operating Officer |
James Edgemond | Chief Financial Officer and Treasurer |
Pat Poisson | Executive Vice President of Technical Operations |
Leigh Peterson | Senior Vice President of Product Development |
Joseph Thome | TD Cowen and Company |
Hartaj Singh | Oppenheimer & Co. |
Jessica Fye | JPMorgan |
Eun Yang | Jefferies |
Andreas Argyrides | Wedbush Securities |
Ashwani Verma | UBS |
Good morning, and welcome to the United Therapeutics Corporation First Quarter 2023 Earnings Webcast. My name is Danielle, and I will be your conference operator today. [Operator Instructions] Please note this call is being recorded. I would now like to turn the webcast over to Dewey Steadman, Head of Investor Relations at United Therapeutics.
Thank you, Danielle, and good morning.